Global Patent Index - EP 1358349 A2

EP 1358349 A2 20031105 - CANCER GENE DETERMINATION AND THERAPEUTIC SCREENING USING SIGNATURE GENE SETS

Title (en)

CANCER GENE DETERMINATION AND THERAPEUTIC SCREENING USING SIGNATURE GENE SETS

Title (de)

BESTIMMUNG VON KREBSGENEN UND THERAPEUTISCHES SCREENINGVERFAHREN DAS SIGNATUREN VON GENSÄTZEN VERWENDET

Title (fr)

DETERMINATION DE GENE DU CANCER ET RECHERCHE THERAPEUTIQUE UTILISANT DES ENSEMBLES DE GENES SIGNATURE

Publication

EP 1358349 A2 20031105 (EN)

Application

EP 01938990 A 20010530

Priority

  • US 0110838 W 20010530
  • US 20947300 P 20000605
  • US 20953100 P 20000605
  • US 23313300 P 20000918
  • US 23361700 P 20000918
  • US 23400900 P 20000920
  • US 23403400 P 20000920
  • US 23405200 P 20000920
  • US 23450900 P 20000922
  • US 23456700 P 20000922
  • US 23492300 P 20000925
  • US 23492400 P 20000925
  • US 23507700 P 20000925
  • US 23508200 P 20000925
  • US 23513400 P 20000925
  • US 23528000 P 20000925
  • US 23563700 P 20000926
  • US 23563800 P 20000926
  • US 23571100 P 20000927
  • US 23572000 P 20000927
  • US 23584000 P 20000927
  • US 23586300 P 20000927
  • US 23602800 P 20000928
  • US 23603200 P 20000928
  • US 23603300 P 20000928
  • US 23603400 P 20000928
  • US 23610900 P 20000928
  • US 23611100 P 20000928
  • US 23684200 P 20000929
  • US 23689100 P 20000929
  • US 23717200 P 20001002
  • US 23717300 P 20001002
  • US 23727800 P 20001002
  • US 23729400 P 20001002
  • US 23729500 P 20001002
  • US 23731600 P 20001002
  • US 23742500 P 20001003
  • US 23759800 P 20001003
  • US 23760400 P 20001003
  • US 23760600 P 20001003
  • US 23760800 P 20001003
  • US 24486700 P 20001101
  • US 24508400 P 20001101

Abstract (en)

[origin: WO0194629A2] Processes for assaying potential antitumor agents based on their modulation of the expression of specified genes, or sets, of suspected cancer cell genes are disclosed, along with methods for diagnosing cancerous, or potentially cancerous, conditions as a result of the expression, or patterns of expression, of such genes, or sets of genes. Also disclosed are methods for determining functionally related genes, or gene sets, as well as methods for treating cancer based on targeting expression products of such genes, or gene sets, and determining genes involved in the cancerous process.

IPC 1-7

C12Q 1/68; G01N 33/50; A61K 39/395; A61K 48/00

IPC 8 full level

C12N 15/09 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/566 (2006.01); G01N 33/574 (2006.01)

CPC (source: EP)

C12Q 1/6886 (2013.01); G01N 33/5011 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01)

Citation (search report)

See references of WO 0194629A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0194629 A2 20011213; WO 0194629 A3 20030904; WO 0194629 A8 20020418; WO 0194629 A8 20020516; AU 2001264559 A8 20011217; AU 6455901 A 20011217; CA 2411601 A1 20011213; EP 1358349 A2 20031105; JP 2004509612 A 20040402

DOCDB simple family (application)

US 0110838 W 20010530; AU 6455901 A 20010530; CA 2411601 A 20010530; EP 01938990 A 20010530; JP 2002502169 A 20010530